[PHARMA] YoY Quarter Result on 30-Sep-2017 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
15-Nov-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
30-Sep-2017 [#3]
Profit Trend
QoQ- -62.39%
YoY- -72.59%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 624,804 716,849 587,660 574,503 515,215 524,413 502,086 3.70%
PBT 4,093 3,885 17,603 15,271 19,923 25,337 24,945 -25.98%
Tax -2,799 -3,509 -2,298 -11,381 -7,275 -5,362 -9,944 -19.03%
NP 1,294 376 15,305 3,890 12,648 19,975 15,001 -33.50%
-
NP to SH 1,442 481 15,051 3,580 13,061 19,971 14,955 -32.25%
-
Tax Rate 68.39% 90.32% 13.05% 74.53% 36.52% 21.16% 39.86% -
Total Cost 623,510 716,473 572,355 570,613 502,567 504,438 487,085 4.19%
-
Net Worth 345,040 516,387 522,618 531,892 531,250 534,373 507,124 -6.21%
Dividend
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Div 3,920 - 13,000 12,973 10,365 23,312 20,698 -24.19%
Div Payout % 271.91% - 86.38% 362.37% 79.37% 116.73% 138.41% -
Equity
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Net Worth 345,040 516,387 522,618 531,892 531,250 534,373 507,124 -6.21%
NOSH 261,705 261,229 260,505 259,821 259,146 259,027 258,737 0.19%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin 0.21% 0.05% 2.60% 0.68% 2.45% 3.81% 2.99% -
ROE 0.42% 0.09% 2.88% 0.67% 2.46% 3.74% 2.95% -
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
RPS 239.03 274.86 226.02 221.42 198.81 202.45 194.05 3.53%
EPS 0.55 0.18 5.79 1.38 5.04 7.71 5.78 -32.40%
DPS 1.50 0.00 5.00 5.00 4.00 9.00 8.00 -24.32%
NAPS 1.32 1.98 2.01 2.05 2.05 2.063 1.96 -6.37%
Adjusted Per Share Value based on latest NOSH - 259,821
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
RPS 43.35 49.74 40.77 39.86 35.75 36.39 34.84 3.70%
EPS 0.10 0.03 1.04 0.25 0.91 1.39 1.04 -32.29%
DPS 0.27 0.00 0.90 0.90 0.72 1.62 1.44 -24.32%
NAPS 0.2394 0.3583 0.3626 0.3691 0.3686 0.3708 0.3519 -6.21%
Price Multiplier on Financial Quarter End Date
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Date 30/09/20 30/09/19 28/09/18 29/09/17 30/09/16 30/09/15 30/09/14 -
Price 4.32 2.44 2.89 4.14 5.58 6.50 4.63 -
P/RPS 1.81 0.89 1.28 1.87 2.81 3.21 2.39 -4.52%
P/EPS 783.09 1,322.99 49.93 300.05 110.71 84.31 80.10 46.17%
EY 0.13 0.08 2.00 0.33 0.90 1.19 1.25 -31.40%
DY 0.35 0.00 1.73 1.21 0.72 1.38 1.73 -23.36%
P/NAPS 3.27 1.23 1.44 2.02 2.72 3.15 2.36 5.58%
Price Multiplier on Announcement Date
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Date 19/11/20 20/11/19 19/11/18 15/11/17 21/11/16 26/11/15 21/11/14 -
Price 5.72 2.21 3.09 3.82 5.70 6.50 4.45 -
P/RPS 2.39 0.80 1.37 1.73 2.87 3.21 2.29 0.71%
P/EPS 1,036.87 1,198.28 53.38 276.85 113.10 84.31 76.99 54.18%
EY 0.10 0.08 1.87 0.36 0.88 1.19 1.30 -34.76%
DY 0.26 0.00 1.62 1.31 0.70 1.38 1.80 -27.54%
P/NAPS 4.33 1.12 1.54 1.86 2.78 3.15 2.27 11.35%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment